Steps to Improve Walking and Reduce Falls in Parkinson's — Tel Aviv & Bologna
Official title: Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna
Run by University of Kiel · NCT07105787 · Data updated 2026-11-12
This trial will test whether speed-dependent treadmill training with mechanical and VR-triggered gait challenges helps people with mild-to-moderate Parkinson's disease walk more stably and transfer those gains to daily life.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | University of Kiel Academic / other |
| Locations | 2 sites (Tel Aviv and 1 other locations) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | March 31, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | August 6, 2025 |
| Trial ID | NCT07105787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people with Parkinson's disease (MDS criteria) in Hoehn & Yahr stages I–III who can walk at least one floor, have a gait-related score on the MDS-UPDRS, can give informed consent, and do not have implanted DBS or major contraindications to exercise.
✕Probably not a fit
Patients with advanced Parkinson's disease, implanted deep brain stimulators, significant cognitive impairment, uncontrolled psychiatric conditions, severe depression, or any medical contraindication to unsupervised exercise are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, site-specific trial applies speed-dependent treadmill training (SDTT) with and without mechanically and VR-triggered gait perturbations to people with Parkinson's disease (Hoehn & Yahr I–III). Participants undergo lab-based kinematic, EMG, and EEG measurements before and after training and are monitored for transfer of improvements to daily-life gait using wearable sensors. The protocol is one of three parallel randomized trials using a shared core design with pooled analysis across sites to examine neural and biomechanical mechanisms and individual response differences. Outcomes include lab gait measures, neural activity changes, gait self-efficacy, and mobility in daily life.
Why it matters
Potential benefit: If successful, the approach could improve walking stability, increase confidence, and reduce falls by tailoring treadmill training to patients' gait and neural profiles.
How similar studies have gone: Previous trials have shown that treadmill training and perturbation-based or VR-augmented approaches can improve gait and reduce falls, but linking those benefits to specific neural mechanisms and predicting individual transfer to daily life is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. Diagnosis of PD according to the MDS Criteria 2. Hoehn and Yahr stages I to III; 3. Movement Disorder Society-sponsored version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS) gait sub-score of 1 or more 4. Signed informed consent to participation Exclusion criteria * Any known general health condition likely to interfere with or to pose a contraindication to non-medically supervised physical exercise. * Moderate or severe depression (BDI-II ≥18) * Cognitive impairment which may preclude the possibility to provide a fully informed consent to enrolment. * Linguistic comprehension capacity less than 75% in ordinary conversation * Severe psychiatric comorbidity which may interfere with compliance to the study protocol History of or current status of substance dependency * Unable to walk less than 1 floor * Thoracic pain in the last 4 weeks * Currently enrolled in other interventional studies * Implanted Deep Brain Stimulation device
Where it's running
-
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel Recruiting -
IRCCS Istituto delle Scienze Neurologiche di Bologna
Bologna, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
VIVI-OLIVE: Multicomponent Exercise and Olive Oil for Older Adults at High Risk of Falls
In adults 75 and older at high risk of falling, this study tests whether a 24-month plan of personalized exercise, Mediterranean diet guidance, and 60 mL of extra virgin olive oil daily can improve walking speed and reduce fall risk.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.